Skip to content

Evaluation of the Efficacy of Crocin on metabolic and Weight Loss of Obese Patients Undergoing Sleeve Gastrectomy Bariatric Surgery

Evaluation of the Efficacy of Crocin on metabolic and Weight Loss of Obese Patients Undergoing Sleeve Gastrectomy Bariatric Surgery

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241023063475N1
Enrollment
74
Registered
2024-11-24
Start date
2024-12-21
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and obesity. Overweight and obesity

Interventions

Intervention 1: Intervention group: A daily dose of 15 mg of crocin (Krocina) will be administered, which will be obtained from Pouyesh Darou Sina Company. The treatment will be given for a duration o

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age range: 20-60 years Obesity candidates for bariatric surgery Normal renal function Normal liver function

Exclusion criteria

Exclusion criteria: sensitivity to crocin substance drug allergy to crocin history of alcohol consumption history of chronic diseases

Design outcomes

Primary

MeasureTime frame
CRP. Timepoint: base and after 90 days. Method of measurement: laboratory kit.;LDL. Timepoint: base and after 90 days. Method of measurement: laboratory kit.;HDL. Timepoint: base and after 90 days. Method of measurement: laboratory kit.;Total Cholesterol. Timepoint: base and after 90 days. Method of measurement: laboratory kit.;AST. Timepoint: base and after 90 days. Method of measurement: laboratory kit.;ALT. Timepoint: base and after 90 days. Method of measurement: laboratory kit.;ALP. Timepoint: base and after 90 days. Method of measurement: laboratory kit.;BUN. Timepoint: base and after 90 days. Method of measurement: laboratory kit.;Creatinine. Timepoint: base and after 90 days. Method of measurement: laboratory kit.;Body Mass Index (BMI). Timepoint: base and after 90 days. Method of measurement: Height measurement tool (stadiometer) and weight measurement tool (scale).;Fasting Blood Sugar. Timepoint: base and after 90 days. Method of measurement: laboratory kit.;Triglyceride. Timepoint: base and after 90 days. Method of measurement: laboratory kit.;Waist circumference. Timepoint: base and after 90 days. Method of measurement: stadiometer.;Waist to hip ratio. Timepoint: base and after 90 days. Method of measurement: stadiometer.;HbA1c. Timepoint: base and after 90 days. Method of measurement: laboratory kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Torkaman Zadeh

Sabzevar University of Medical Sciences

leila_torkamanzadeh@yahoo.com+98 51 4401 8101

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026